EE489 The Cost of Treatment with Dupilumab in Severe Asthma Patients With Coexisting Other Type 2 Inflammatory Diseases
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.732
https://www.valueinhealthjournal.com/article/S1098-3015(22)02936-9/fulltext
Title :
EE489 The Cost of Treatment with Dupilumab in Severe Asthma Patients With Coexisting Other Type 2 Inflammatory Diseases
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02936-9&doi=10.1016/j.jval.2022.09.732
First page :
Section Title :
Open access? :
No
Section Order :
10273